Clinical Trials of Texas

Clinical Trials of Texas (CTT) is a premier multi-specialty clinical research site based in San Antonio, Texas. Founded in 2001, the company conducts Phase I-IV clinical trials across a wide range of therapeutic areas, including metabolic disorders, neuroscience, and infectious diseases. CTT is recognized for its high enrollment rates and quality data, serving major pharmaceutical companies and contract research organizations (CROs). In 2021, the company was acquired by Headlands Research, a leading network of clinical trial sites backed by KKR. CTT operates a dedicated Phase I unit and maintains a large database of diverse study participants to support global drug development programs.